Logo image of MIT.MI

MITTEL SPA (MIT.MI) Stock Fundamental Analysis

BIT:MIT - Euronext Milan - IT0001447348 - Common Stock - Currency: EUR

1.745  0 (0%)

Fundamental Rating

6

MIT gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 47 industry peers in the Financial Services industry. MIT has an excellent profitability rating, but there are some minor concerns on its financial health. MIT is valued correctly, but it does not seem to be growing. MIT also has an excellent dividend rating. These ratings would make MIT suitable for dividend investing!


Dividend Valuation Growth Profitability Health

Quickly go to:

9

1. Profitability

1.1 Basic Checks

In the past year MIT was profitable.
MIT had a positive operating cash flow in the past year.
Each year in the past 5 years MIT has been profitable.
Each year in the past 5 years MIT had a positive operating cash flow.
MIT.MI Yearly Net Income VS EBIT VS OCF VS FCFMIT.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M -20M 40M 60M

1.2 Ratios

With an excellent Return On Assets value of 12.51%, MIT belongs to the best of the industry, outperforming 88.00% of the companies in the same industry.
Looking at the Return On Equity, with a value of 19.94%, MIT is in the better half of the industry, outperforming 72.00% of the companies in the same industry.
The Return On Invested Capital of MIT (19.42%) is better than 90.00% of its industry peers.
MIT had an Average Return On Invested Capital over the past 3 years of 14.88%. This is above the industry average of 10.14%.
The last Return On Invested Capital (19.42%) for MIT is above the 3 year average (14.88%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 12.51%
ROE 19.94%
ROIC 19.42%
ROA(3y)4.19%
ROA(5y)2.58%
ROE(3y)6.68%
ROE(5y)4.21%
ROIC(3y)14.88%
ROIC(5y)11.03%
MIT.MI Yearly ROA, ROE, ROICMIT.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5 -5 10 15

1.3 Margins

MIT's Profit Margin of 33.36% is fine compared to the rest of the industry. MIT outperforms 72.00% of its industry peers.
MIT's Profit Margin has improved in the last couple of years.
MIT has a Operating Margin of 49.36%. This is amongst the best in the industry. MIT outperforms 86.00% of its industry peers.
MIT's Operating Margin has improved in the last couple of years.
MIT has a Gross Margin of 100.33%. This is amongst the best in the industry. MIT outperforms 100.00% of its industry peers.
MIT's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 49.36%
PM (TTM) 33.36%
GM 100.34%
OM growth 3Y8.63%
OM growth 5Y58.53%
PM growth 3Y215%
PM growth 5Y95.71%
GM growth 3Y0.76%
GM growth 5Y10.13%
MIT.MI Yearly Profit, Operating, Gross MarginsMIT.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100 -100 -200

More info and screens

6

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so MIT is creating value.
The number of shares outstanding for MIT remains at a similar level compared to 1 year ago.
MIT has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, MIT has an improved debt to assets ratio.
MIT.MI Yearly Shares OutstandingMIT.MI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M
MIT.MI Yearly Total Debt VS Total AssetsMIT.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M

2.2 Solvency

An Altman-Z score of 2.36 indicates that MIT is not a great score, but indicates only limited risk for bankruptcy at the moment.
MIT has a Altman-Z score of 2.36. This is comparable to the rest of the industry: MIT outperforms 58.00% of its industry peers.
MIT has a Debt/Equity ratio of 0.18. This is a healthy value indicating a solid balance between debt and equity.
MIT's Debt to Equity ratio of 0.18 is fine compared to the rest of the industry. MIT outperforms 70.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF N/A
Altman-Z 2.36
ROIC/WACC3.26
WACC5.96%
MIT.MI Yearly LT Debt VS Equity VS FCFMIT.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100M 200M 300M

2.3 Liquidity

A Current Ratio of 2.89 indicates that MIT has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 2.89, MIT belongs to the top of the industry, outperforming 84.00% of the companies in the same industry.
A Quick Ratio of 1.90 indicates that MIT should not have too much problems paying its short term obligations.
MIT has a better Quick ratio (1.90) than 80.00% of its industry peers.
Industry RankSector Rank
Current Ratio 2.89
Quick Ratio 1.9
MIT.MI Yearly Current Assets VS Current LiabilitesMIT.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M

More info and screens

2

3. Growth

3.1 Past

Measured over the past years, MIT shows a very strong growth in Earnings Per Share. The EPS has been growing by 106.03% on average per year.
Looking at the last year, MIT shows a decrease in Revenue. The Revenue has decreased by -2.49% in the last year.
Measured over the past years, MIT shows a small growth in Revenue. The Revenue has been growing by 5.85% on average per year.
EPS 1Y (TTM)N/A
EPS 3Y204.32%
EPS 5Y106.03%
EPS Q2Q%-91.85%
Revenue 1Y (TTM)-2.49%
Revenue growth 3Y-3.54%
Revenue growth 5Y5.85%
Sales Q2Q%25.86%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
MIT.MI Yearly Revenue VS EstimatesMIT.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M
MIT.MI Yearly EPS VS EstimatesMIT.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 -0.05 -0.1 -0.15

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

MIT is valuated cheaply with a Price/Earnings ratio of 2.81.
Based on the Price/Earnings ratio, MIT is valued cheaper than 92.00% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 27.45. MIT is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 2.81
Fwd PE N/A
MIT.MI Price Earnings VS Forward Price EarningsMIT.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of MIT indicates a rather cheap valuation: MIT is cheaper than 92.00% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 1.23
MIT.MI Per share dataMIT.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3

4.3 Compensation for Growth

The excellent profitability rating of MIT may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.03
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

8

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 7.04%, MIT is a good candidate for dividend investing.
MIT's Dividend Yield is rather good when compared to the industry average which is at 3.79. MIT pays more dividend than 90.00% of the companies in the same industry.
MIT's Dividend Yield is rather good when compared to the S&P500 average which is at 2.38.
Industry RankSector Rank
Dividend Yield 7.04%

5.2 History

On average, the dividend of MIT grows each year by 31.64%, which is quite nice.
Dividend Growth(5Y)31.64%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

The dividend of MIT is growing, but earnings are growing more, so the dividend growth is sustainable.
DPN/A
EPS Next 2YN/A
EPS Next 3YN/A
MIT.MI Yearly Income VS Free CF VS DividendMIT.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M -20M 40M

More info and screens

MITTEL SPA

BIT:MIT (3/5/2025, 10:29:18 AM)

1.745

0 (0%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryFinancial Services
Earnings (Last)N/A N/A
Earnings (Next)04-22 2025-04-22
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners79.04%
Ins Owner ChangeN/A
Market Cap141.96M
Analysts84
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 7.04%
Yearly Dividend0.01
Dividend Growth(5Y)31.64%
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 2.81
Fwd PE N/A
P/S 0.94
P/FCF N/A
P/OCF 16.71
P/B 0.56
P/tB 0.77
EV/EBITDA 1.23
EPS(TTM)0.62
EY35.53%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.14
FCFYN/A
OCF(TTM)0.1
OCFY5.98%
SpS1.86
BVpS3.11
TBVpS2.26
PEG (NY)N/A
PEG (5Y)0.03
Profitability
Industry RankSector Rank
ROA 12.51%
ROE 19.94%
ROCE 22.74%
ROIC 19.42%
ROICexc 25.34%
ROICexgc 34.77%
OM 49.36%
PM (TTM) 33.36%
GM 100.34%
FCFM N/A
ROA(3y)4.19%
ROA(5y)2.58%
ROE(3y)6.68%
ROE(5y)4.21%
ROIC(3y)14.88%
ROIC(5y)11.03%
ROICexc(3y)18.47%
ROICexc(5y)13.76%
ROICexgc(3y)25.01%
ROICexgc(5y)18.45%
ROCE(3y)17.14%
ROCE(5y)12.72%
ROICexcg growth 3Y36.07%
ROICexcg growth 5Y64.28%
ROICexc growth 3Y32.02%
ROICexc growth 5Y65.98%
OM growth 3Y8.63%
OM growth 5Y58.53%
PM growth 3Y215%
PM growth 5Y95.71%
GM growth 3Y0.76%
GM growth 5Y10.13%
F-Score5
Asset Turnover0.38
Health
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF N/A
Debt/EBITDA 0.54
Cap/Depr 198.12%
Cap/Sales 13.09%
Interest Coverage 28.12
Cash Conversion 10.03%
Profit Quality N/A
Current Ratio 2.89
Quick Ratio 1.9
Altman-Z 2.36
F-Score5
WACC5.96%
ROIC/WACC3.26
Cap/Depr(3y)179.03%
Cap/Depr(5y)134.19%
Cap/Sales(3y)13.45%
Cap/Sales(5y)10.74%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)N/A
EPS 3Y204.32%
EPS 5Y106.03%
EPS Q2Q%-91.85%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-2.49%
Revenue growth 3Y-3.54%
Revenue growth 5Y5.85%
Sales Q2Q%25.86%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-4.29%
EBIT growth 3Y4.78%
EBIT growth 5Y67.8%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-514.1%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-79.3%
OCF growth 3Y-29.55%
OCF growth 5Y-15.3%